Stability study of human serum albumin pharmaceutical preparations

被引:33
作者
Oliva, A [1 ]
Santoveña, A [1 ]
Llabres, M [1 ]
Fariña, JB [1 ]
机构
[1] Univ La Laguna, Fac Farm, Dept Ingn Quim & Tecnol Farmaceut, Tenerife 38200, Spain
关键词
D O I
10.1211/0022357991772574
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The influence of temperature on the stability of human serum albumin (HSA) pharmaceutical preparations has been studied by size-exclusion high-performance liquid chromatography with multi-angle laser-light-scattering detection and by particle-size analysis. The behaviour of HSA in two pharmaceutical preparations stored at different temperatures (40, 55 and 70 degrees C) followed the same pattern-an increase in the relative percentage of dimer (MW 132 000 Da) and aggregate (MW > 200 000 Da), and then a decrease in the concentration of all species and, finally, sudden protein coagulation. These results suggest a time- and temperature-dependent process. At 70 degrees C, monomer only was detected for both preparations; the amount remaining was 83 and 72% for formulations A and B, respectively. Analysis of size-distribution curves also seems to confirm these results. Initially, three distributions were observed with length-volume mean diameters (d(l,v)) of 1.67, 10.6 and 57 mu m. After 80 days at 55 degrees C, only two distributions were observed, with d(l,v) of 3.07 and 76 mu m. An additional study using pure HSA at different concentrations (0.3, 2.5, 5 and 10% w/v) and storage at 75 degrees C was performed to determine the influence of the concentration of auxiliary substances and of the HSA. Only when the HSA concentration was 0.3% w/v did the remaining fraction of HSA fit a Prout-Thompkins nucleation model. Initially three distributions with mean sizes of 2, 20 and 40 mu m were observed whereas at the end of the assay only one distribution, mean size 129 mu m, was seen. The methodology used enabled us to separate the HSA degradation products and to determine the absolute molecular weight of albumin monomer and dimer. It is possible to conclude that the degradation mechanism for the formulations studied is complex, and that it is possible to fit the degradation data to Preut-Thompkins kinetics only when the concentration of HSA is low enough (0.3% w/v).
引用
收藏
页码:385 / 392
页数:8
相关论文
共 20 条
[1]  
CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153
[2]   SOLID-PHASE AGGREGATION OF PROTEINS UNDER PHARMACEUTICALLY RELEVANT CONDITIONS [J].
COSTANTINO, HR ;
LANGER, R ;
KLIBANOV, AM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (12) :1662-1669
[3]   STUDIES ON MOLECULAR-WEIGHT DETERMINATION USING REFRACTIVE-INDEX AND MULTI-ANGLE LASER-LIGHT SCATTERING DETECTORS IN SIZE-EXCLUSION CHROMATOGRAPHY [J].
DAYAL, U ;
MEHTA, SK .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1994, 17 (02) :303-316
[4]  
*EUR PHARM, 1997, ALB HUM, P255
[5]  
Glatz C.E., 1992, STABILITY PROTEIN PH, P135
[6]  
GRANT E, 1988, STAT QUALITY CONTROL, P302
[7]   STABILITY OF INTERLEUKIN-1-BETA (IL-1-GAMMA) IN AQUEOUS-SOLUTION - ANALYTICAL METHODS, KINETICS, PRODUCTS, AND SOLUTION FORMULATION IMPLICATIONS [J].
GU, LC ;
ERDOS, EA ;
CHIANG, HS ;
CALDERWOOD, T ;
TSAI, K ;
VISOR, GC ;
DUFFY, J ;
HSU, WC ;
FOSTER, LC .
PHARMACEUTICAL RESEARCH, 1991, 8 (04) :485-490
[8]  
HENDERSON A, 1996, ALL ALBUMIN BIOCH GE, P1
[9]   A BAYESIAN-ANALYSIS OF THE LINEAR CALIBRATION-PROBLEM [J].
HUNTER, WG ;
LAMBOY, WF .
TECHNOMETRICS, 1981, 23 (04) :323-328
[10]   THE AGGREGATION OF BOVINE SERUM-ALBUMIN IN SOLUTION AND IN THE SOLID-STATE [J].
JORDAN, GM ;
YOSHIOKA, S ;
TERAO, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1994, 46 (03) :182-185